What is Blue Biofuels Inc's earnings per share (EPS)?

Blue Biofuels Inc (BIOF) reported diluted earnings per share of $-0.01 for fiscal year 2025. This represents a -80.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Blue Biofuels Inc Financials

BIOF

Source SEC Filings (10-K/10-Q) Updated Mar 19, 2026 Currency USD FYE March

This page shows Blue Biofuels Inc (BIOF) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 12 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Earnings Quality Low Quality

0.29x

For every $1 of reported earnings, Blue Biofuels Inc generates $0.29 in operating cash flow (-$845K OCF vs -$2.9M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Interest Coverage At Risk

-151.8x

Blue Biofuels Inc earns $-151.8 in operating income for every $1 of interest expense (-$3.7M vs $24K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

N/A

EBITDA

-$3.6M

YoY+9.4%

Blue Biofuels Inc's EBITDA was -$3.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 9.4% from the prior year.

Net Income

-$2.9M

YoY-102.6%

Blue Biofuels Inc reported -$2.9M in net income in fiscal year 2025. This represents a decrease of 102.6% from the prior year.

EPS (Diluted)

$-0.01

YoY-80.0%

Blue Biofuels Inc earned $-0.01 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 80.0% from the prior year.

Cash & Balance Sheet

Free Cash Flow

-$914K

YoY+15.0%

Blue Biofuels Inc generated -$914K in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 15.0% from the prior year.

Cash & Debt

N/A

Dividends Per Share

N/A

Shares Outstanding

320M

YoY+4.0%

5Y CAGR+5.8%

10Y CAGR+23.0%

Blue Biofuels Inc had 320M shares outstanding in fiscal year 2025. This represents an increase of 4.0% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

N/A

Net Margin

N/A

Return on Equity

N/A

Capital Allocation

R&D Spending

$2.3M

YoY-1.0%

5Y CAGR+24.7%

Blue Biofuels Inc invested $2.3M in research and development in fiscal year 2025. This represents a decrease of 1.0% from the prior year.

Share Buybacks

N/A

Capital Expenditures

$69K

YoY-3.1%

5Y CAGR-14.1%

10Y CAGR-6.8%

Blue Biofuels Inc invested $69K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 3.1% from the prior year.

BIOF Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	$2.3M-1.0%	$2.3M+25.9%	$1.8M-21.3%	$2.4M+113.0%	$1.1M+44.6%	$763K
SG&A Expenses	$1.4M-18.3%	$1.7M+28.8%	$1.3M-13.1%	$1.5M+49.0%	$1.0M-15.7%	$1.2M
Operating Income	-$3.7M+8.4%	-$4.1M-27.1%	-$3.2M+18.9%	-$3.9M-81.1%	-$2.2M-9.1%	-$2.0M
Interest Expense	$24K	N/A	N/A	N/A	N/A	N/A
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	-$2.9M-102.6%	-$1.4M+53.6%	-$3.1M+22.9%	-$4.0M-85.1%	-$2.1M+1.9%	-$2.2M
EPS (Diluted)	$-0.01-80.0%	$-0.01+50.0%	$-0.01	N/A	N/A	N/A

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	$486K+3.0%	$471K+34.4%	$351K	N/A	$411K+41.0%	$291K-52.0%	$608K	N/A
SG&A Expenses	$351K-18.7%	$431K+27.5%	$338K	N/A	$237K-5.1%	$250K-15.6%	$296K	N/A
Operating Income	-$836K+7.4%	-$903K-31.0%	-$689K	N/A	-$648K-19.7%	-$541K+40.1%	-$904K	N/A
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	-$423K+54.1%	-$921K-277.6%	-$244K	N/A	$1.9M+440.0%	-$549K+42.0%	-$947K	N/A
EPS (Diluted)	$-0.00+66.7%	$-0.00-200.0%	$-0.00	N/A	$0.01+400.0%	$-0.00+33.3%	$-0.00	N/A

BIOF Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	N/A	$1.4M+34.9%	$1.0M-6.8%	$1.1M-39.8%	$1.8M+106.0%	$893K
Current Assets	N/A	$81K+5.9%	$77K-69.9%	$255K-78.9%	$1.2M+264.5%	$332K
Cash & Equivalents	N/A	$49K+19.0%	$41K-80.6%	$212K-81.8%	$1.2M+306.4%	$287K
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	N/A	$4.2M-7.7%	$4.6M+32.6%	$3.5M+7.1%	$3.2M-23.5%	$4.2M
Current Liabilities	N/A	$2.2M+47.2%	$1.5M+135.3%	$639K+28.7%	$496K-54.8%	$1.1M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	$100K
Total Equity	N/A	-$2.8M+20.1%	-$3.6M-51.1%	-$2.4M-68.8%	-$1.4M+58.2%	-$3.3M
Retained Earnings	N/A	-$57.3M-2.5%	-$55.8M-5.8%	-$52.8M-8.1%	-$48.8M-4.6%	-$46.7M

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Total Assets	$1.5M+2.6%	$1.4M-2.3%	$1.5M+6.7%	$1.4M-6.7%	$1.5M+14.1%	$1.3M+33.6%	$977K-5.1%	$1.0M
Current Assets	$107K+447.5%	$19K-51.4%	$40K-50.7%	$81K-62.4%	$216K-50.9%	$440K+671.5%	$57K-25.6%	$77K
Cash & Equivalents	$95K+1086.1%	$8K+5.8%	$8K-84.5%	$49K-67.3%	$149K-63.4%	$408K+1576.9%	$24K-40.7%	$41K
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$4.5M-1.7%	$4.6M+4.2%	$4.4M+4.7%	$4.2M+5.9%	$4.0M-34.0%	$6.1M+16.6%	$5.2M+13.2%	$4.6M
Current Liabilities	$2.4M-2.3%	$2.5M+5.2%	$2.3M+5.3%	$2.2M+12.9%	$2.0M-1.5%	$2.0M-3.8%	$2.1M+37.6%	$1.5M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	-$3.1M+3.6%	-$3.2M-7.5%	-$3.0M-3.7%	-$2.8M-13.3%	-$2.5M+47.1%	-$4.8M-12.6%	-$4.2M-18.5%	-$3.6M
Retained Earnings	-$58.8M-0.7%	-$58.4M-1.6%	-$57.5M-0.4%	-$57.3M-3.2%	-$55.5M+3.3%	-$57.3M-1.0%	-$56.8M-1.7%	-$55.8M

BIOF Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	-$845K+15.8%	-$1.0M+37.3%	-$1.6M+21.4%	-$2.0M+17.4%	-$2.5M-167.5%	-$921K
Capital Expenditures	$69K-3.1%	$71K-75.3%	$288K+108.3%	$138K-36.1%	$216K+47.0%	$147K
Free Cash Flow	-$914K+15.0%	-$1.1M+43.1%	-$1.9M+13.2%	-$2.2M+18.9%	-$2.7M-150.9%	-$1.1M
Investing Cash Flow	-$137K-18.6%	-$116K+63.9%	-$321K-55.9%	-$206K+11.8%	-$233K-13.0%	-$206K
Financing Cash Flow	$999K-11.4%	$1.1M-35.6%	$1.8M+35.8%	$1.3M-64.0%	$3.6M+174.3%	$1.3M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Operating Cash Flow	-$154K+50.7%	-$312K-2426.6%	$13K+106.3%	-$212K+14.5%	-$248K+13.7%	-$288K-12.4%	-$256K-141.5%	-$106K
Capital Expenditures	-$67K-313.4%	$32K-69.9%	$105K	N/A	N/A	N/A	N/A	$6K
Free Cash Flow	-$221K+35.6%	-$344K-276.8%	-$91K	N/A	N/A	N/A	N/A	-$112K
Investing Cash Flow	$66K+271.0%	-$39K+75.0%	-$155K-80.7%	-$86K-722.3%	-$10K-1140.5%	$1K+104.8%	-$21K-63.7%	-$13K
Financing Cash Flow	$175K-50.2%	$351K+251.3%	$100K-49.2%	$197K	$0-100.0%	$670K+157.7%	$260K+246.7%	$75K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

BIOF Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	N/A	-102.1%+194.4pp	-296.6%+61.5pp	-358.1%-241.7pp	-116.4%+128.0pp	-244.4%
Current Ratio	N/A	0.04-0.0	0.05-0.3	0.40-2.0	2.44+2.1	0.30
Debt-to-Equity	N/A	-1.49-0.2	-1.29+0.2	-1.47+0.8	-2.32-2.3	-0.03
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	-28.4%+35.2pp	-63.6%-47.1pp	-16.4%	N/A	125.3%+167.4pp	-42.0%+54.9pp	-96.9%	N/A
Current Ratio	0.04+0.0	0.010.0	0.02-0.0	0.04-0.1	0.11-0.1	0.22+0.2	0.03-0.0	0.05
Debt-to-Equity	-1.49-0.0	-1.46+0.0	-1.50-0.0	-1.49+0.1	-1.59-0.3	-1.27-0.0	-1.23+0.1	-1.29
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Similar Companies

Nano One Materia NNOMF

$73.5M

Graphene Mfg Gro GMGMF

$196.0M

Kraig Biocraft Laboratories In KBLB

$118.9M

Airboss Of Ameri ABSSF

$154.5M

Greystone Logist GLGI

$7.9M

Frequently Asked Questions

Is Blue Biofuels Inc profitable?

No, Blue Biofuels Inc (BIOF) reported a net income of -$2.9M in fiscal year 2025.

What is Blue Biofuels Inc's EBITDA?

Blue Biofuels Inc (BIOF) had EBITDA of -$3.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is Blue Biofuels Inc's free cash flow?

Blue Biofuels Inc (BIOF) generated -$914K in free cash flow during fiscal year 2025. This represents a 15.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Blue Biofuels Inc's operating cash flow?

Blue Biofuels Inc (BIOF) generated -$845K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Blue Biofuels Inc's capital expenditures?

Blue Biofuels Inc (BIOF) invested $69K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Blue Biofuels Inc spend on research and development?

Blue Biofuels Inc (BIOF) invested $2.3M in research and development during fiscal year 2025.

How many shares does Blue Biofuels Inc have outstanding?

Blue Biofuels Inc (BIOF) had 320M shares outstanding as of fiscal year 2025.

Are Blue Biofuels Inc's earnings high quality?

Blue Biofuels Inc (BIOF) has an earnings quality ratio of 0.29x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Blue Biofuels Inc cover its interest payments?

Blue Biofuels Inc (BIOF) has an interest coverage ratio of -151.8x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.